title: Interaction between prostanoids and nitric oxide in the control of tubular function in rats with chronic bile duct ligation.
abstract: Recent work indicates that both nitric oxide and cyclooxygenase products play an important role in the renal alterations of liver cirrhosis, although the interactions between them have not been completely established. The purpose of this study was to assess the effect of simultaneous blockade of nitric oxide synthase and cyclooxygenase in rats with chronic bile duct ligation and in control, sham-operated rats. Compared with control rats, chronic bile duct ligation rats, 23-25 days after surgery, showed a decreased mean arterial pressure, natriuresis, and kaliuresis, without differences in glomerular filtration rate, and an increased urinary nitrite excretion. Nitric oxide synthesis inhibition by administration of N(G)-nitro-L-arginine methyl ester induced, in control rats, an increase in mean arterial pressure, without significant changes in natriuresis or glomerular filtration rate. In chronic bile duct ligation rats, N(G)-nitro-L-arginine methyl ester induced an increase in mean arterial pressure, natriuresis, and kaliuresis, together with a reduction in urinary nitrite excretion and an increase in prostaglandin E2 excretion. Cyclooxygenase inhibition with indomethacin induced in both experimental groups a marked inhibition in urinary prostaglandin E2 excretion without significant changes in Na+ or K+ excretion, and a significant increase in urinary nitrite excretion in control rats. N(G)-Nitro-L-arginine methyl ester in addition to indomethacin prevented the indomethacin-induced increase in nitrite excretion and dramatically reduced sodium excretion in both experimental groups. Thus, the present study suggests that both nitric oxide and cyclooxygenase products interact in the control of urinary sodium excretion and that each system is activated in the absence of the other one.
authors.affiliation: Instituto Reina Sofía de Investigaciones Nefrológicas, Departamento de Fisiología y Farmacología, Universidad de Salamanca, Spain.
authors.forename: M
authors.initials: M
authors.lastname: Criado
authors.forename: O
authors.initials: O
authors.lastname: Flores
authors.forename: F
authors.initials: F
authors.lastname: Hidalgo
authors.forename: J M
authors.initials: JM
authors.lastname: López-Novoa
authors.forename: A
authors.initials: A
authors.lastname: Sánchez-Rodríguez
mesh_terms: D000818:Animals; D001794:Blood Pressure; D001835:Body Weight; D016861:Cyclooxygenase Inhibitors / Q000494:pharmacology; D005260:Female; D006339:Heart Rate; D007213:Indomethacin / Q000494:pharmacology; D007684:Kidney Tubules / Q000503:physiopathology*; D008105:Liver Cirrhosis, Biliary / Q000503:physiopathology*; D019331:NG-Nitroarginine Methyl Ester / Q000494:pharmacology; D009569:Nitric Oxide / Q000502:physiology*; D011453:Prostaglandins / Q000502:physiology*; D051381:Rats; D017208:Rats, Wistar
chemical_list: D016861:Cyclooxygenase Inhibitors; D011453:Prostaglandins; D009569:Nitric Oxide; D019331:NG-Nitroarginine Methyl Ester; D007213:Indomethacin